Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

GLP-1RA therapy may increase the risk of hair loss.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

GLP-1 agonists may increase the risk of hair loss.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

TSH is not reliable for detecting hypothyroidism after bariatric surgery; FT3/rT3 ratio is better.

People with polycystic ovary syndrome have higher levels of Gremlin-1.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

Feeding goats more during the non-growing period increases cashmere yield and length.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Improved nutrition quickly healed the patient's skin lesions.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

GLP-1 RAs may help wound healing but can also cause faster facial aging and skin issues.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.

Low leptin levels in obese women with high testosterone may indicate a tumor that secretes male hormones.

Weight-loss drugs are not linked to suicidal thoughts.

The document concludes that a high-protein, low-carb diet can lead to significant weight loss but requires caution and further research.

Mealworm protein helps fat cell development and may aid in metabolic health and hair growth.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Gastric exclusion surgery caused major weight loss and health improvements but led to some anemia and vitamin deficiencies.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Semaglutide may worsen eating disorders in vulnerable individuals.

The VMH AMPK-SNS-BAT axis may help treat cachexia and obesity.

Ongoing follow-up and dietary counseling are crucial for maintaining health benefits after metabolic surgery.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Late dumping syndrome after fundoplication can be diagnosed with an oral glucose tolerance test and managed with diet changes.